Company profile

Neurimmune AG

More news about Neurimmune AG

09.04.2024 13:00

Clinical success for Neurimmune

Please login or
register to use the
awards follow feature
02.02.2024 15:40

Biogen returns global IP rights on Alzheimer’s drug to Neurimmune

Please login or
register to use the
awards follow feature
30.05.2023 14:21

Positive results for Swiss biotechs’ clinical studies

Please login or
register to use the
awards follow feature
07.01.2022 16:30

Neurimmune and AstraZeneca join forces

Please login or
register to use the
awards follow feature
07.06.2021 17:34

FDA approves Alzheimer’s drug of Neurimmune

Please login or
register to use the
awards follow feature
07.08.2020 14:55

Neurimmune’s therapy against Alzheimer’s closer to approval

Please login or
register to use the
awards follow feature
09.04.2020 09:48

Smart answers to the corona virus

Please login or
register to use the
awards follow feature
18.10.2019 08:52

AL-S Pharma announces start of clinical trial

Please login or
register to use the
awards follow feature
18.09.2018 16:50

Neurimmune to receive a milestone payment from Ono Pharmaceuticals

Please login or
register to use the
awards follow feature
02.05.2018 11:15

Funds for Neurimmune to fight Alzheimer’s Disease

Please login or
register to use the
awards follow feature
09.11.2017 12:45

Neurimmune to receive funding from its new partner from Japan

Please login or
register to use the
awards follow feature
25.10.2017 14:00

Neurimmune raises $150 Million to finance its growth strategy

Please login or
register to use the
awards follow feature
30.01.2017 11:31

Neurimmune Projekt mit Pfizer Forschungspreis ausgezeichnet

Please login or
register to use the
awards follow feature
08.12.2016 08:39

Neurimmune spins off AL-S Pharma

Please login or
register to use the
awards follow feature
17.12.2014 07:31

Encouraging results for Neurimmune’s Alzheimer antibody

Please login or
register to use the
awards follow feature
Neurimmune AG

Founded
2006

Kanton
ZH

Homepage

rss